Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen

ASTA issued comments to the Food and Drug Administration (FDA) in December 2018 in response to the FDA's Request for Comment on Sesame as an Allergen in Foods. The comments support labeling sesame as a major allergen, provided that sufficient time is offered to implement new labeling and GMP requirements.

ASTA issued comments to the U.S. House of Representatives in November 2011 requesting that the House accept the Senate's higher amount of FY12 funding for the Food and Drug Administration in the FY 2012 Agriculture Appropriations budget.